返回 Agenda
Session 3 Track 3:COVID-19 Experience from the Field – An HCP Panel
Session Chair(s)
Lori Mouser, PHARMD
Senior Director, Global Head of Oncology Scientific Engagement and Congresses
Daiichi Sankyo Inc., Switzerland
Paul Minne, PHARMD, RPH
Senior Director, MSL Team
Neurocrine Biosciences, United States
This panel discussion will explore the impact of the COVID-19 pandemic on interactions with Health Care Providers (HCPs). A diverse group of HCPs will share their experiences of managing engagements with MSLs, attending virtual congresses, delivering care virtually and provide ideas on how these experiences may shape future approaches.
Learning Objective : At the conclusion of this session, participants should be able to:
- Discuss the primary challenges facing HCPs in conducting virtual engagements with MSLs
- List ways that virtual congress engagements have been successful for HCPs to access new data
- Identify future engagement strategies that meet HCP needs in the post COVID era
Speaker(s)
Panelists
James S Pratty, MD
University of California, Riverside, United States
Assistant Clinical Professor, Psychiatry
Panelist
Melissa Mitchell, PHARMD
RUHS Medical Center, United States
Senior Clinical Pharmacist – Special Projects
Panelists
Joshua Sabari, MD
NYU Langone Health, Permutter Cancer Center, United States
Attending Physician, Thoracic Medical Oncology